Cargando…
Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies
Precision medicine has recently emerged as a promising strategy for cancer therapy because it not only specifically targets cancer cells but it also does not have adverse effects on normal cells. Oligonucleotide aptamers are a class of small molecule ligands that can specifically bind to their targe...
Autores principales: | Yang, Shuanghui, Li, Huan, Xu, Ling, Deng, Zhenhan, Han, Wei, Liu, Yanting, Jiang, Wenqi, Zu, Youli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172475/ https://www.ncbi.nlm.nih.gov/pubmed/30292138 http://dx.doi.org/10.1016/j.omtn.2018.08.023 |
Ejemplares similares
-
Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
por: Sun, Hongguang, et al.
Publicado: (2014) -
Oligonucleotide aptamers for pathogen detection and infectious disease control
por: Wan, Quanyuan, et al.
Publicado: (2021) -
Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy
por: Zeng, Zihua, et al.
Publicado: (2020) -
ssDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 Cells
por: Yu, Ge, et al.
Publicado: (2016) -
Specific and Sensitive Tumor Imaging Using Biostable Oligonucleotide Aptamer Probes
por: Zeng, Zihua, et al.
Publicado: (2014)